ZFN is a kind of artificially synthesized restriction endonuclease, which consists of a nonspecific cleavage domain of the Flavobacterium okeanokoites-derived FokI and a DNA-binding zinc-finger domain. At present, in many species such as plants, fruit flies, zebrafish, frogs, moose, and cattle, ZFN technology has been widely used to locate gene variations and new species with genetic backgrounds can be generated through artificial genome information. It is also of great value in the medical field, has potential significance for gene therapy of diseases, and has very broad application prospects.
Fig.1 ZFN mechanism. (Hillary & Ceasar, 2021)
Gene editing is an emerging genetic engineering technology that more accurately modifies specific target genes in the genome of an organism. The gene editing tool is a sequence-specific endonuclease composed of a sequence-specific DNA binding domain and a non-specific DNA modification domain. The gene editing process is summarized as one search, two cuts, and three repairs. Identify DNA target sites on chromosomes (find), cut and generate DNA double-strand breaks (shear), and induce DNA damage repair (repair), thereby achieving directional editing of the specified genome. Simply put, gene editing is to use of a modified protein as a tool to carry out targeted modification of a specified gene.
We utilize ZFNs to create complementary DNA overhangs (sticky ends) in both the genomic target site and the donor DNA allowing its integration.
Fig.2 ZFN-based glycogene editing technology. (CD BioGlyco)
CD BioGlyco possesses a professional platform for in vitro and in vivo Genome Editing Experiments, providing a comprehensive glycogene editing service. From study design to product/service selection, sample collection, report, and biological interpretation, our experts guide you in every step. Your research success is our goal. If you have any special requirements, welcome to feel free to contact us for custom service. We look forward to your happy cooperation.
Reference: